SK285474B6 - Primárne balenie obsahujúce vodný roztok na parenterálne podávanie a spôsob jeho výroby - Google Patents

Primárne balenie obsahujúce vodný roztok na parenterálne podávanie a spôsob jeho výroby Download PDF

Info

Publication number
SK285474B6
SK285474B6 SK282-2001A SK2822001A SK285474B6 SK 285474 B6 SK285474 B6 SK 285474B6 SK 2822001 A SK2822001 A SK 2822001A SK 285474 B6 SK285474 B6 SK 285474B6
Authority
SK
Slovakia
Prior art keywords
primary package
solution
package according
rubber
melagatran
Prior art date
Application number
SK282-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK2822001A3 (en
Inventor
Anna Lundgren
Mats Sundgren
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK2822001A3 publication Critical patent/SK2822001A3/sk
Publication of SK285474B6 publication Critical patent/SK285474B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/062—Carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
SK282-2001A 1998-09-01 1999-08-24 Primárne balenie obsahujúce vodný roztok na parenterálne podávanie a spôsob jeho výroby SK285474B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802938A SE9802938D0 (sv) 1998-09-01 1998-09-01 Improved stability for injection solutions
PCT/SE1999/001440 WO2000012043A1 (en) 1998-09-01 1999-08-24 Improved stability for injection solutions

Publications (2)

Publication Number Publication Date
SK2822001A3 SK2822001A3 (en) 2001-08-06
SK285474B6 true SK285474B6 (sk) 2007-02-01

Family

ID=20412436

Family Applications (1)

Application Number Title Priority Date Filing Date
SK282-2001A SK285474B6 (sk) 1998-09-01 1999-08-24 Primárne balenie obsahujúce vodný roztok na parenterálne podávanie a spôsob jeho výroby

Country Status (34)

Country Link
US (4) US6576245B1 (ru)
EP (1) EP1109526B1 (ru)
JP (1) JP2002523184A (ru)
KR (1) KR100614162B1 (ru)
CN (1) CN1230141C (ru)
AR (1) AR033788A1 (ru)
AT (1) ATE262882T1 (ru)
AU (1) AU754447C (ru)
BR (1) BR9913261A (ru)
CA (1) CA2340238C (ru)
CZ (1) CZ2001743A3 (ru)
DE (1) DE69916082T2 (ru)
DK (1) DK1109526T3 (ru)
EE (1) EE04768B1 (ru)
ES (1) ES2217808T3 (ru)
HK (1) HK1035482A1 (ru)
HU (1) HUP0104161A3 (ru)
ID (1) ID28015A (ru)
IL (2) IL141333A0 (ru)
IS (1) IS2230B (ru)
MY (1) MY120822A (ru)
NO (1) NO322292B1 (ru)
NZ (1) NZ509985A (ru)
PL (1) PL195244B1 (ru)
PT (1) PT1109526E (ru)
RU (1) RU2224499C2 (ru)
SA (1) SA99200573B1 (ru)
SE (1) SE9802938D0 (ru)
SK (1) SK285474B6 (ru)
TR (1) TR200100679T2 (ru)
TW (1) TWI228987B (ru)
UA (1) UA73282C2 (ru)
WO (1) WO2000012043A1 (ru)
ZA (1) ZA200101590B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US6802828B2 (en) * 2001-11-23 2004-10-12 Duoject Medical Systems, Inc. System for filling and assembling pharmaceutical delivery devices
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
DK1594434T3 (da) * 2003-01-14 2017-01-02 Yeda Res & Dev Company Ltd At The Weizmann Inst Of Science Parenterale formuleringer af peptide til behandling af systemisk lupus erythematosus
KR100505557B1 (ko) * 2003-02-10 2005-08-03 조을룡 약병마개 제조용 고무 조성물
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
US20070166187A1 (en) * 2006-01-18 2007-07-19 Song Jing F Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
CN103957966B (zh) * 2011-09-27 2017-09-29 贝克顿迪金森法国公司 等离子体处理过的硅油作为医用注射装置中的涂层的用途
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381779A (en) 1981-07-16 1983-05-03 Sterling Drug Inc. Deformable slidable piston to provide self-aspiration in hypodermic cartridge ampoules
DK0390244T3 (da) * 1989-03-28 1993-02-08 Duphar Int Res Forfyldt injektionsanordning omfattende en cylinder, hvori en væskeformig diazepamformulering er in-desluttet
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
SE9501472D0 (sv) 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9601556D0 (sv) 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions

Also Published As

Publication number Publication date
US6576245B1 (en) 2003-06-10
EP1109526A1 (en) 2001-06-27
KR20010073070A (ko) 2001-07-31
US20060233778A1 (en) 2006-10-19
WO2000012043A1 (en) 2000-03-09
US20040235731A1 (en) 2004-11-25
AU754447B2 (en) 2002-11-14
CN1230141C (zh) 2005-12-07
EE200100131A (et) 2002-06-17
ID28015A (id) 2001-05-03
NZ509985A (en) 2002-12-20
SA99200573B1 (ar) 2006-09-20
IL141333A0 (en) 2002-03-10
AU754447C (en) 2006-10-19
TWI228987B (en) 2005-03-11
IL141333A (en) 2006-07-05
AR033788A1 (es) 2004-01-07
EE04768B1 (et) 2007-02-15
KR100614162B1 (ko) 2006-08-25
US20030190310A1 (en) 2003-10-09
PT1109526E (pt) 2004-07-30
SK2822001A3 (en) 2001-08-06
CN1314804A (zh) 2001-09-26
US6660279B2 (en) 2003-12-09
UA73282C2 (en) 2005-07-15
RU2224499C2 (ru) 2004-02-27
IS2230B (is) 2007-04-15
NO322292B1 (no) 2006-09-11
PL346471A1 (en) 2002-02-11
HUP0104161A2 (hu) 2002-04-29
ES2217808T3 (es) 2004-11-01
EP1109526B1 (en) 2004-03-31
MY120822A (en) 2005-11-30
SE9802938D0 (sv) 1998-09-01
DE69916082D1 (de) 2004-05-06
BR9913261A (pt) 2001-05-22
TR200100679T2 (tr) 2001-07-23
AU5890399A (en) 2000-03-21
CZ2001743A3 (cs) 2002-01-16
DK1109526T3 (da) 2004-07-05
ATE262882T1 (de) 2004-04-15
US6998136B2 (en) 2006-02-14
HK1035482A1 (en) 2001-11-30
NO20011032D0 (no) 2001-02-28
CA2340238C (en) 2009-01-06
DE69916082T2 (de) 2004-10-21
PL195244B1 (pl) 2007-08-31
HUP0104161A3 (en) 2002-08-28
JP2002523184A (ja) 2002-07-30
ZA200101590B (en) 2002-05-27
IS5845A (is) 2001-02-15
CA2340238A1 (en) 2000-03-09
NO20011032L (no) 2001-04-30
SA99200573A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
SK285474B6 (sk) Primárne balenie obsahujúce vodný roztok na parenterálne podávanie a spôsob jeho výroby
EP3908259A1 (en) A stable parenteral dosage form of cetrorelix acetate
US20220096414A1 (en) Levothyroxine liquid formulations
AU2003200467B2 (en) Improved stability for injection solutions
NZ295492A (en) Storage stable aqueous infusion for iv administration comprising a thrombin inhibitor
MXPA01001930A (en) Improved stability for injection solutions
WO1992010747A1 (en) Container system for storage stable pharmaceuticals
WO2023037383A1 (en) Formulations of immune check point inhibitors
Airaudo et al. Comparative study of the sorption of clomipramine and viloxazine hydrochlorides in Stedim 6^{\hbox {\psyrfont\char210}} and PVC bags

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100824